| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |